NCT07295730

Brief Summary

The goal of this clinical trial is to learn if 3D-printed heart models and augmented reality can be useful modalities to teach medical students about congenital heart disease. The main questions it aims to answer are:

  1. 1.Does using 3D-printed heart models improve learners' understanding of congenital heart disease when compared to traditional slide-based teaching methods?
  2. 2.Does using augmented reality heart models improve learners' understanding of congenital heart disease when compared to traditional slide-based teaching methods?
  3. 3.How can these modalities best be integrated into standard medical school curricula?
  4. 4.Take a pre-test consisting of questions regarding anatomy and physiology of the normal heart as well as two congenital heart diseases.
  5. 5.Be randomized into 3 groups that receive a teaching session using either slide-based lecture, 3D-printed models, or augmented reality.
  6. 6.Take a post-test of the same questions from the pre-test.
  7. 7.Take a delayed post-test of the same questions with additional subjective questions about their experience with their assigned modality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2025

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2025

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

December 10, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 22, 2025

Completed
Last Updated

December 26, 2025

Status Verified

December 1, 2025

Enrollment Period

19 days

First QC Date

December 10, 2025

Last Update Submit

December 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in Pre and Post-test Scores

    Participants completed a 16-item, multiple choice questionnaire about the anatomy and physiology of the normal heart and two complex congenital heart defects. The questionnaire is broken down into 4 questions on basic cardiology and 6 questions each pertaining specifically to tetralogy of Fallot and hypoplastic left heart syndrome. The questionnaire is delivered pre-intervention, immediately post-intervention, and again at 3-weeks post intervention. Correct answers are scored as true (1) and incorrect answers scored as false (0) with a score range of 0-16 with higher scores indicating better retention and understanding of the curriculum.

    Enrollment Pre-Intervention, Baseline Post-Intervention, and 3 Weeks Post-Intervention

Study Arms (3)

Slide-based lecture

OTHER

Participants in this group received teaching using a slide-based lecture

Other: 3D-printed heart models and augmented reality

3D-printed Model

ACTIVE COMPARATOR

This group received teaching using 3D-printed models

Other: 3D-printed heart models and augmented reality

Augmented Reality

ACTIVE COMPARATOR

This group received teaching using augmented reality headsets

Other: 3D-printed heart models and augmented reality

Interventions

Participants will receive an educational session regarding congenital heart disease using a slide-based lecture, 3D-printed models, or augmented reality headsets.

3D-printed ModelAugmented RealitySlide-based lecture

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • First year medical student

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Case Western Reserve University School of Medicine

Cleveland, Ohio, 44106, United States

Location

MeSH Terms

Conditions

Tetralogy of FallotHypoplastic Left Heart Syndrome

Condition Hierarchy (Ancestors)

Heart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Arpit Agarwal, MD

    University Hospitals Cleveland Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2025

First Posted

December 22, 2025

Study Start

November 20, 2025

Primary Completion

December 9, 2025

Study Completion

December 9, 2025

Last Updated

December 26, 2025

Record last verified: 2025-12

Locations